Forte Biosciences: Funding, Investors & Team (Sep 2026)
Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.
Forte Biosciences has raised $150M across 1 funding round on record, the most recent an undisclosed round of $150M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Forte Biosciences Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Forte Biosciences Funding Rounds
Forte Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Forte Biosciences Funding Compared to Other Biotechnology Startups
Forte Biosciences' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Forte Biosciences in Biotechnology and Sherman Oaks
Companies Similar to Forte Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Forte Biosciences Funding FAQs
What does Forte Biosciences do?
Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.
How much funding has Forte Biosciences raised?
Forte Biosciences has raised $150M across 1 round on record. The most recent is an undisclosed round of $150M announced in Apr 2026.
When did Forte Biosciences last raise funding?
Forte Biosciences' most recent funding round on record is an undisclosed round of $150M, announced in Apr 2026.
Who founded Forte Biosciences?
FundedIQ lists Paul Wagner (Founder) at Forte Biosciences.
Where is Forte Biosciences headquartered?
Forte Biosciences is based in Sherman Oaks, California, United States.
How many employees does Forte Biosciences have?
Forte Biosciences is in the 11-50 employee band.
How does Forte Biosciences' funding compare to other Biotechnology startups?
Forte Biosciences' latest round of $150M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Forte Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Forte Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.